99 related articles for article (PubMed ID: 18158940)
1. A change of in vivo characteristics depending on specific activity of radioiodinated (+)-2-[4-(4-iodophenyl)piperidino]cyclohexanol [(+)-pIV] as a ligand for sigma receptor imaging.
Akhter N; Shiba K; Ogawa K; Tsuji S; Kinuya S; Nakajima K; Mori H
Nucl Med Biol; 2008 Jan; 35(1):29-34. PubMed ID: 18158940
[TBL] [Abstract][Full Text] [Related]
2. In vivo characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino] cyclohexanol as a potential sigma-1 receptor imaging agent.
Akhter N; Shiba K; Ogawa K; Kinuya S; Nakajima K; Mori H
Nucl Med Biol; 2007 Aug; 34(6):697-702. PubMed ID: 17707810
[TBL] [Abstract][Full Text] [Related]
3. In vitro characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino]cyclohexanol [(+)-pIV] as a sigma-1 receptor ligand.
Shiba K; Ogawa K; Mori H
Bioorg Med Chem; 2005 Feb; 13(4):1095-9. PubMed ID: 15670917
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluation of [
Shigeno T; Kozaka T; Kitamura Y; Ogawa K; Taki J; Kinuya S; Shiba K
Ann Nucl Med; 2021 Feb; 35(2):167-175. PubMed ID: 33417152
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of a radiobromine-labeled sigma ligand for tumor imaging.
Ogawa K; Kanbara H; Kiyono Y; Kitamura Y; Kiwada T; Kozaka T; Kitamura M; Mori T; Shiba K; Odani A
Nucl Med Biol; 2013 May; 40(4):445-50. PubMed ID: 23528561
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of radioiodinated vesamicol analogs for sigma receptor imaging in tumor and radionuclide receptor therapy.
Ogawa K; Shiba K; Akhter N; Yoshimoto M; Washiyama K; Kinuya S; Kawai K; Mori H
Cancer Sci; 2009 Nov; 100(11):2188-92. PubMed ID: 19659515
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of [18F]fluoroethyl SA4503 as a PET ligand for the sigma receptor.
Elsinga PH; Kawamura K; Kobayashi T; Tsukada H; Senda M; Vaalburg W; Ishiwata K
Synapse; 2002 Mar; 43(4):259-67. PubMed ID: 11835521
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of an astatine-211-labeled sigma receptor ligand for alpha radionuclide therapy.
Ogawa K; Mizuno Y; Washiyama K; Shiba K; Takahashi N; Kozaka T; Watanabe S; Shinohara A; Odani A
Nucl Med Biol; 2015 Nov; 42(11):875-9. PubMed ID: 26235266
[TBL] [Abstract][Full Text] [Related]
9. In vivo evaluation of [(11)C]SA4503 as a PET ligand for mapping CNS sigma(1) receptors.
Kawamura K; Ishiwata K; Tajima H; Ishii S; Matsuno K; Homma Y; Senda M
Nucl Med Biol; 2000 Apr; 27(3):255-61. PubMed ID: 10832082
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro validation and in vivo pharmacokinetics of [125I]N-[2-(4-iodophenyl)ethyl]-N-methyl-2-(1-piperidinyl) ethylamine: a high-affinity ligand for imaging sigma receptor positive tumors.
John CS; Gulden ME; Vilner BJ; Bowen WD
Nucl Med Biol; 1996 Aug; 23(6):761-6. PubMed ID: 8940718
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, in vitro binding, and tissue distribution of radioiodinated 2-[125I]N-(N-benzylpiperidin-4-yl)-2-iodo benzamide, 2-[125I]BP: a potential sigma receptor marker for human prostate tumors.
John CS; Gulden ME; Li J; Bowen WD; McAfee JG; Thakur ML
Nucl Med Biol; 1998 Apr; 25(3):189-94. PubMed ID: 9620622
[TBL] [Abstract][Full Text] [Related]
12. In Vivo Differences between Two Optical Isomers of Radioiodinated o-iodo-trans-decalinvesamicol for Use as a Radioligand for the Vesicular Acetylcholine Transporter.
Uno I; Kozaka T; Miwa D; Kitamura Y; Azim MA; Ogawa K; Taki J; Kinuya S; Shiba K
PLoS One; 2016; 11(1):e0146719. PubMed ID: 26752172
[TBL] [Abstract][Full Text] [Related]
13. Sigma1 and sigma2 receptor binding affinity and selectivity of SA4503 and fluoroethyl SA4503.
Lever JR; Gustafson JL; Xu R; Allmon RL; Lever SZ
Synapse; 2006 May; 59(6):350-8. PubMed ID: 16463398
[TBL] [Abstract][Full Text] [Related]
14. In vivo evaluation of radioiodinated 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)-piperazine derivatives as new ligands for sigma receptor imaging using single photon emission computed tomography.
Hirata M; Mori T; Soga S; Umeda T; Ohmomo Y
Biol Pharm Bull; 2006 Oct; 29(10):2009-15. PubMed ID: 17015942
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, in vitro pharmacologic characterization, and preclinical evaluation of N-[2-(1'-piperidinyl)ethyl]-3-[125I]iodo-4-methoxybenzamide (P[125I]MBA) for imaging breast cancer.
John CS; Bowen WD; Fisher SJ; Lim BB; Geyer BC; Vilner BJ; Wahl RL
Nucl Med Biol; 1999 May; 26(4):377-82. PubMed ID: 10382840
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro evaluation of iodinated derivatives of piperazine as a new ligand for sigma receptor imaging by single photon emission computed tomography.
Hirata M; Mori T; Soga S; Umeda T; Ohmomo Y
Chem Pharm Bull (Tokyo); 2006 Apr; 54(4):470-5. PubMed ID: 16595947
[TBL] [Abstract][Full Text] [Related]
17. Radioiodinated (-)-2-[4-(3-iodophenyl) piperidino] cyclohexanol: a potential radioligand for mapping presynaptic cholinergic neurons.
Shiba K; Mori H; Matsuda H; Ichikawa A; Tonami N
Nucl Med Commun; 1996 Jun; 17(6):485-92. PubMed ID: 8822746
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of a 18F-labeled spirocyclic piperidine derivative as promising σ1 receptor imaging agent.
Chen YY; Wang X; Zhang JM; Deuther-Conrad W; Zhang XJ; Huang Y; Li Y; Ye JJ; Cui MC; Steinbach J; Brust P; Liu BL; Jia HM
Bioorg Med Chem; 2014 Oct; 22(19):5270-8. PubMed ID: 25189691
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and pharmacological characterization of 4-[125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide: a high affinity sigma receptor ligand for potential imaging of breast cancer.
John CS; Vilner BJ; Gulden ME; Efange SM; Langason RB; Moody TW; Bowen WD
Cancer Res; 1995 Jul; 55(14):3022-7. PubMed ID: 7606722
[TBL] [Abstract][Full Text] [Related]
20. Substituted halogenated arylsulfonamides: a new class of sigma receptor binding tumor imaging agents.
John CS; Lim BB; Vilner BJ; Geyer BC; Bowen WD
J Med Chem; 1998 Jul; 41(14):2445-50. PubMed ID: 9651150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
